Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXa
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 170, 133-141
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: More Choices Bring More ChallengesHospital Pharmacy, 2013
- Inhibition of Intrinsic Xase by Protein SArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitroBlood, 2011
- Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exositeBlood, 2009
- Sequence variants and haplotypes of the factor IX gene and the risk of venous thrombosisJournal of Thrombosis and Haemostasis, 2008
- Sequence and structural properties of identical mutations with varying phenotypes in human coagulation factor IXProteins: Structure, Function, and Bioinformatics, 2008
- Efficient Thrombin Generation Requires Molecular Phosphatidylserine, Not a Membrane SurfaceBiochemistry, 2005
- Specificity of Soluble Phospholipid Binding Sites on Human Factor XaBiochemistry, 2002
- Genetic Susceptibility to Venous ThrombosisNew England Journal of Medicine, 2001
- High Plasma Levels of Factor VIII and the Risk of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2000